Prestige Consumer Healthcare EBITDA Margin 2010-2024 | PBH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Prestige Consumer Healthcare (PBH) over the last 10 years. The current EBITDA margin for Prestige Consumer Healthcare as of June 30, 2024 is .
| Prestige Consumer Healthcare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $1.11B | $0.37B | 32.88% |
| 2024-03-31 | $1.13B | $0.38B | 33.69% |
| 2023-12-31 | $1.13B | $0.02B | 1.41% |
| 2023-09-30 | $1.13B | $0.02B | 1.42% |
| 2023-06-30 | $1.13B | $0.01B | 1.15% |
| 2023-03-31 | $1.13B | $0.02B | 1.33% |
| 2022-12-31 | $1.11B | $0.37B | 33.63% |
| 2022-09-30 | $1.11B | $0.37B | 33.33% |
| 2022-06-30 | $1.09B | $0.36B | 33.09% |
| 2022-03-31 | $1.09B | $0.37B | 33.70% |
| 2021-12-31 | $1.06B | $0.36B | 33.96% |
| 2021-09-30 | $1.02B | $0.35B | 34.15% |
| 2021-06-30 | $0.98B | $0.34B | 34.99% |
| 2021-03-31 | $0.94B | $0.33B | 35.31% |
| 2020-12-31 | $0.96B | $0.34B | 35.04% |
| 2020-09-30 | $0.96B | $0.34B | 35.25% |
| 2020-06-30 | $0.96B | $0.33B | 34.69% |
| 2020-03-31 | $0.96B | $0.32B | 33.54% |
| 2019-12-31 | $0.95B | $0.10B | 10.07% |
| 2019-09-30 | $0.95B | $0.10B | 10.29% |
| 2019-06-30 | $0.95B | $0.10B | 10.70% |
| 2019-03-31 | $0.98B | $0.11B | 10.77% |
| 2018-12-31 | $0.99B | $0.24B | 23.94% |
| 2018-09-30 | $1.02B | $0.24B | 23.82% |
| 2018-06-30 | $1.04B | $0.25B | 23.87% |
| 2018-03-31 | $1.04B | $0.26B | 24.47% |
| 2017-12-31 | $1.03B | $0.33B | 32.23% |
| 2017-09-30 | $0.97B | $0.31B | 32.27% |
| 2017-06-30 | $0.93B | $0.31B | 33.12% |
| 2017-03-31 | $0.88B | $0.24B | 27.18% |
| 2016-12-31 | $0.85B | $0.25B | 29.65% |
| 2016-09-30 | $0.83B | $0.25B | 29.53% |
| 2016-06-30 | $0.82B | $0.24B | 29.61% |
| 2016-03-31 | $0.81B | $0.29B | 36.35% |
| 2015-12-31 | $0.79B | $0.29B | 36.55% |
| 2015-09-30 | $0.79B | $0.28B | 36.01% |
| 2015-06-30 | $0.76B | $0.26B | 33.77% |
| 2015-03-31 | $0.72B | $0.23B | 32.73% |
| 2014-12-31 | $0.67B | $0.21B | 32.04% |
| 2014-09-30 | $0.62B | $0.20B | 32.36% |
| 2014-06-30 | $0.60B | $0.21B | 34.28% |
| 2014-03-31 | $0.60B | $0.21B | 35.62% |
| 2013-12-31 | $0.61B | $0.22B | 36.14% |
| 2013-09-30 | $0.62B | $0.23B | 36.71% |
| 2013-06-30 | $0.62B | $0.23B | 36.53% |
| 2013-03-31 | $0.62B | $0.22B | 35.48% |
| 2012-12-31 | $0.60B | $0.19B | 31.67% |
| 2012-09-30 | $0.55B | $0.16B | 28.96% |
| 2012-06-30 | $0.49B | $0.14B | 27.38% |
| 2012-03-31 | $0.44B | $0.12B | 26.30% |
| 2011-12-31 | $0.40B | $0.11B | 27.54% |
| 2011-09-30 | $0.39B | $0.10B | 25.77% |
| 2011-06-30 | $0.36B | $0.10B | 26.39% |
| 2011-03-31 | $0.34B | $0.09B | 26.49% |
| 2010-12-31 | $0.31B | $0.09B | 29.32% |
| 2010-09-30 | $0.29B | $0.10B | 34.48% |
| 2010-06-30 | $0.29B | $0.10B | 33.11% |
| 2010-03-31 | $0.29B | $0.10B | 32.42% |
| 2009-12-31 | $0.28B | $0.09B | 32.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.663B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |